0001567619-20-012731.txt : 20200630
0001567619-20-012731.hdr.sgml : 20200630
20200630214818
ACCESSION NUMBER: 0001567619-20-012731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200430
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mueller Brian
CENTRAL INDEX KEY: 0001514980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 201003867
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2020-04-30
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001514980
Mueller Brian
105 DIGITAL DRIVE
NOVATO
CA
94949
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2020-04-30
5
A
0
323
62.586
A
25104
D
Common Stock
2020-06-29
4
A
0
4640
0
A
29744
D
Stock Option (Right to buy Common Stock)
122.18
2020-06-29
4
A
0
13230
0
A
2021-06-29
2030-06-28
Common Stock
13230
13230
D
Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.
Restricted stock units granted on June 29, 2020. Price not applicable.
Option grant vests 12/48th on June 29, 2021 and 1/48th on the 29th day of each month thereafter.
/s/ Eric Fleekop, Attorney-in-Fact
2020-06-30